VTRO (Vitro Biopharma) Total Inventories: $0.28 Mil (As of Oct. 2022)


What is Vitro Biopharma Total Inventories?

Vitro Biopharma VTRO Total Inventories is $0.28 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's total inventories for the quarter that ended in Oct. 2022 was $0.28 Mil. Vitro Biopharma's average total inventories from the quarter that ended in Oct. 2021 to the quarter that ended in Oct. 2022 was $0.20 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Vitro Biopharma's Net-Net Working Capital per share for the quarter that ended in Oct. 2022 was $-0.04.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Vitro Biopharma's Days Inventory for the three months ended in Oct. 2022 was 30.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. Vitro Biopharma's Inventory Turnover for the quarter that ended in Oct. 2022 was 2.95.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vitro Biopharma's Inventory-to-Revenue for the quarter that ended in Oct. 2022 was 0.06.


Vitro Biopharma  (AMEX:VTRO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Vitro Biopharma's Net-Net Working Capital Per Share for the quarter that ended in Oct. 2022 is

Net-Net Working Capital Per Share (Q: Oct. 2022 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.742+0.75 * 0.074+0.5 * 0.28-5.738
-0-0)/107.725
=-0.04

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vitro Biopharma's Days Inventory for the three months ended in Oct. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Oct. 2022 )/Cost of Goods Sold (Q: Oct. 2022 )*Days in Period
=0.199/0.587*365 / 4
=30.93

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Vitro Biopharma's Inventory Turnover for the quarter that ended in Oct. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Oct. 2022 ) / Average Total Inventories (Q: Oct. 2022 )
=0.587 / 0.199
=2.95

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vitro Biopharma's Inventory to Revenue for the quarter that ended in Oct. 2022 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Oct. 2022 ) / Revenue (Q: Oct. 2022 )
=0.199 / 3.293
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Vitro Biopharma Total Inventories Related Terms


Vitro Biopharma Total Inventories Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Total Inventories Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 0.03 0.12 0.28

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.03 0.12 0.28

Vitro Biopharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.28 Mil mean?
Vitro Biopharma (VTRO) has a Total Inventories of $0.28 Mil as of Oct. 2022. The total amount of inventory as recorded on a company's balance sheet. View historical data for Vitro Biopharma and its competitors.
Is Vitro Biopharma's Total Inventories too high?
Vitro Biopharma's current Total Inventories is $0.28 Mil.
How does Vitro Biopharma's Total Inventories compare to ?
Vitro Biopharma's Total Inventories of $0.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Vitro Biopharma and its competitors. Vitro Biopharma's current Total Inventories is $0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Total Inventories of $0.28 Mil. The current Total Inventories is $0.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Total Inventories is $0.28 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.